Epidemiological study to describe Non Small Cell Lung Cancer (NSCLC) clinical management patterns in Central Eastern Europe and Russia (Lung-EPICLIN) - EPICLIN

Study identifier:NIS-ORU-IRE-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Epidemiological study to describe NSCLC clinical management patterns in Central Eastern Europe and Russia. Lung-EPICLIN

Medical condition

Non Small Cell Lung Cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

840

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Feb 2010
Primary Completion Date: 01 Mar 2011
Study Completion Date: 01 Mar 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria